Evoke Pharma Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2025 to a ratio of 5.23, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2025. Average collection period, for Evoke Pharma Inc 's accounts receivable remained unchanged at 70 days, in the Sep 30 2025 quarter.

If we take a look into Healthcare sector 138 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2025 from 1161 to 1186.

What is Receivable Turnover Ratio?
What is Evoke Pharma Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

EVOK Receivables Turnover Ratio	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Receivable Change	57.75 %	45.05 %	72.98 %	259.6 %	63.91 %
Y / Y Revenue Change	61.4 %	47.06 %	77.48 %	97.4 %	69.83 %
Receivable Turnover Ratio (TTM)	5.23	5.19	5.18	5.19	5.6
EVOK's Total Ranking	# 1186	# 1161	# 966	# 1394	# 2335
Accounts Receivable average collection period days	70	70	70	70	65
Seq. Receivable Change	9.81 %	15.69 %	3.76 %	19.67 %	0.97 %
Seq. Revenue Change	14.17 %	21.82 %	-6.9 %	24.65 %	4.03 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 31
Healthcare Sector	# 139
Overall Market	# 1186

Receivable Turnover Ratio Statistics
High	Average	Low
0.88	0.37	-0.21
(Sep 30 2025)		(Sep 30 2017)

EVOK Company Profile • Back to EVOK Efficiency Comparisons • Compare EVOK Receivables Turnover Ratio to its Competitors

Financial Statements
Evoke Pharma Inc 's Accounts Receivable	$ 3 Millions	Visit EVOK's Balance sheet
Evoke Pharma Inc 's Sales TTM	$ 14 Millions	Visit EVOK's Income Statement
Sources of EVOK's Revenues		Visit EVOK's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
EVOK's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
EVOK's Growth Rates	EVOK's Roa	EVOK's Inventory Turnover Ratio	EVOK's Dividend Comparisons
EVOK's Profitability Ratios	EVOK's Roi	EVOK's Asset Turnover Ratio	EVOK's Dividend Growth
EVOK's Valuation Ratios	EVOK's Roe	EVOK's Financial Strength Ratios	EVOK's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2025	Receivable at quarter ending Sep 30 2025
Sutro Biopharma Inc	12.39	$ 105.646 Millions	$ 8.525 Millions
Escalon Medical Corp	12.32	$ 11.940 Millions	$ 0.969 Millions
Scorpius Holdings inc	12.30	$ 1.716 Millions	$ 0.140 Millions
Skinhealth Systems Inc	12.29	$ 301.672 Millions	$ 24.538 Millions
Harvard Apparatus Regenerative Technology Inc	12.23	$ 0.743 Millions	$ 0.061 Millions
Cytokinetics Incorporated	12.08	$ 87.211 Millions	$ 7.220 Millions
Option Care Health Inc	12.01	$ 5,532.505 Millions	$ 460.534 Millions
Corcept Therapeutics Inc	11.86	$ 741.172 Millions	$ 62.498 Millions
Ss Innovations International Inc	11.86	$ 40.946 Millions	$ 3.454 Millions
Chemed Corporation	11.80	$ 2,530.634 Millions	$ 214.372 Millions
Precision Biosciences Inc	11.78	$ 0.698 Millions	$ 0.059 Millions
Ethema Health Corporation	11.72	$ 15.420 Millions	$ 1.315 Millions
Nrc Health	11.70	$ 139.104 Millions	$ 11.886 Millions
Semler Scientific inc	11.45	$ 36.957 Millions	$ 3.226 Millions
Teladoc Health Inc	11.45	$ 2,528.199 Millions	$ 220.826 Millions
Lifeloc Technologies Inc	11.09	$ 8.664 Millions	$ 0.781 Millions
Nexgel Inc	10.99	$ 9.479 Millions	$ 0.863 Millions
Vaxart Inc	10.93	$ 148.204 Millions	$ 13.565 Millions
10x Genomics Inc	10.92	$ 639.482 Millions	$ 58.542 Millions
Integrated Biopharma Inc	10.90	$ 52.210 Millions	$ 4.790 Millions
National Healthcare Corp	10.88	$ 1,500.618 Millions	$ 137.894 Millions
Tandem Diabetes Care Inc	10.78	$ 1,005.832 Millions	$ 93.295 Millions
Arbutus Biopharma Corp	10.58	$ 14.606 Millions	$ 1.380 Millions
Sanuwave Health Inc	10.54	$ 41.283 Millions	$ 3.916 Millions
Lifestance Health Group Inc	10.46	$ 1,367.570 Millions	$ 130.682 Millions
Exact Sciences Corporation	10.37	$ 3,080.353 Millions	$ 297.039 Millions
Novavax inc	10.30	$ 1,064.651 Millions	$ 103.341 Millions
Addus Homecare Corp	10.13	$ 1,346.751 Millions	$ 132.909 Millions
Sintx Technologies Inc	9.96	$ 1.270 Millions	$ 0.128 Millions
Lensar Inc	9.92	$ 59.141 Millions	$ 5.965 Millions

Date modified: 2026-10-05T11:03:38+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.